Does 4-factor prothrombin concentrate (4F-PCC) reduce 24 h blood product consumption in trauma patients at risk of massive transfusion?

被引：0
|
作者：
Newton, Hailey [1 ]
Drew, Doran [1 ,2 ]
Perry, Jeffrey J. [1 ,3 ]
机构：
[1] Univ Ottawa, Ottawa Hosp, Dept Emergency Med, Ottawa, ON, Canada
[2] Univ Ottawa, Dept Surg, Div Trauma, Ottawa, ON, Canada
[3] Ottawa Hosp Res Inst, Ottawa, ON, Canada
来源：
CANADIAN JOURNAL OF EMERGENCY MEDICINE | 2023年 / 25卷 / 12期
关键词：
D O I：
10.1007/s43678-023-00587-y
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：946 / 948
页数：3
相关论文
共 37 条
  • [1] Does 4-factor prothrombin concentrate (4F-PCC) reduce 24 h blood product consumption in trauma patients at risk of massive transfusion?
    Hailey Newton
    Doran Drew
    Jeffrey J. Perry
    Canadian Journal of Emergency Medicine, 2023, 25 : 946 - 948
  • [2] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [3] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Jing Tao
    Elena N. Bukanova
    Shamsuddin Akhtar
    Journal of Intensive Care, 6
  • [4] Tolerability and effectiveness of 4-factor prothrombin complex concentrate (4F-PCC) for warfarin and non-warfarin reversals
    Santibanez, M.
    Lesch, C. A.
    Lin, L.
    Berger, K.
    JOURNAL OF CRITICAL CARE, 2018, 48 : 183 - 190
  • [5] Evaluation of the impact of weight estimations on anticoagulation reversal with 4-factor prothrombin complex concentrate (4F-PCC) in the emergency department
    Vidal, Jennifer
    Procopio, Gabrielle
    Faley, Brian
    PHARMACOTHERAPY, 2016, 36 (12): : E230 - E230
  • [6] Efficacy and Safety of Early Administration of 4-Factor Prothrombin Complex Concentrate in Patients With Trauma at Risk of Massive Transfusion The PROCOAG Randomized Clinical Trial
    Bouzat, Pierre
    Charbit, Jonathan
    Abback, Paer-Selim
    Huet-Garrigue, Delphine
    Delhaye, Nathalie
    Leone, Marc
    Marcotte, Guillaume
    David, Jean-Stephane
    Levrat, Albrice
    Asehnoune, Karim
    Pottecher, Julien
    Duranteau, Jacques
    Courvalin, Elie
    Adolle, Anais
    Sourd, Dimitri
    Bosson, Jean-Luc
    Riou, Bruno
    Gauss, Tobias
    Payen, Jean-Francois
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (16): : 1367 - 1375
  • [7] Evaluation of the prothrombotic potential of four-factor prothrombin complex concentrate (4F-PCC) in animal models
    Ghosh, Subhajit
    Krege, Wilfred
    Doerr, Baerbel
    Mischnik, Marcel
    Pragst, Ingo
    Dickneite, Gerhard
    Herzog, Eva
    PLOS ONE, 2021, 16 (10):
  • [8] Utility of 4-Factor Prothrombin Complex Concentrate in Trauma and Acute-Care Surgical Patients
    Sellers, William
    Bendas, Charles
    Toy, Frederick
    Klock, Brian
    Kerestes, Jamie
    Young, Amanda
    Badger, Clint
    Jensen, Jason
    Becker, Natasha
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2018, 118 (12): : 789 - 797
  • [9] SAFETY AND EFFICACY OF A FIXED-DOSE FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) PROTOCOL
    Villegas, Skylar
    Gutwald, Taylor
    Wilkinson, Kent
    Finoli, Lauren
    Jenniches, Daniel
    Merkel, Alison
    Reardon, Caitlin
    Young, Sarah
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 405 - 405
  • [10] SAFETY OF A 4-FACTOR PROTHROMBIN COMPLEX CONCENTRATE (4F-PCC) VERSUS PLASMA FOR VITAMIN K ANTAGONIST REVERSAL: AN INTEGRATED DATA ANALYSIS OF TWO PHASE III CLINICAL TRIALS
    Milling, Truman J.
    Refaai, Majed A.
    Sarode, Ravi
    Lewis, Brandon
    Mangione, Antoinette
    Durn, Billie L.
    Goldstein, Joshua N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E26 - E26
1234